Bo M. Kang
Chuncheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Therapeutic Intervention of an Intranasally Administered Monoclonal Antibody Targeting the SARS-CoV-2 Omicron Spike Protein Against SARS-CoV-2 Omicron Infection in Mice.
Journal: Viral immunology
Published: June 04, 2025
Parental Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Predominates Over Coinfected SARS-CoV-2 Delta, Producing Less Lethal Variants in a Long-Term Replication Mouse Model.
Journal: Journal of medical virology
Published: August 07, 2024
Production of a monoclonal antibody targeting the SARS-CoV-2 Omicron spike protein and analysis of SARS-CoV-2 Omicron mutations related to monoclonal antibody resistance.
Journal: Microbes and infection
Published: August 01, 2024
A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality.
Journal: Journal of medical virology
Published: November 17, 2023
Analysis of SARS-CoV-2 Mutations after Nirmatrelvir Treatment in a Lung Cancer Xenograft Mouse Model.
Journal: Biomolecules & therapeutics
Published: November 06, 2023
Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2.
Journal: Frontiers in cellular and infection microbiology
Published: August 21, 2023
In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein.
Journal: Journal of medical virology
Published: December 23, 2022
Toward atomistic models of intact severe acute respiratory syndrome coronavirus 2 via Martini coarse-grained molecular dynamics simulations.
Journal: Quantitative biology (Beijing, China)
Published: December 06, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026